131 related articles for article (PubMed ID: 24123265)
1. Small proline rich protein 2a in benign and malignant liver disease.
Mizuguchi Y; Isse K; Specht S; Lunz JG; Corbitt N; Takizawa T; Demetris AJ
Hepatology; 2014 Mar; 59(3):1130-43. PubMed ID: 24123265
[TBL] [Abstract][Full Text] [Related]
2. SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis.
Specht S; Isse K; Nozaki I; Lunz JG; Demetris AJ
Clin Exp Metastasis; 2013 Oct; 30(7):877-90. PubMed ID: 23728799
[TBL] [Abstract][Full Text] [Related]
3. Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.
Demetris AJ; Specht S; Nozaki I; Lunz JG; Stolz DB; Murase N; Wu T
J Hepatol; 2008 Feb; 48(2):276-88. PubMed ID: 18155796
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics.
Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
PLoS One; 2012; 7(2):e32449. PubMed ID: 22384255
[TBL] [Abstract][Full Text] [Related]
5. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
[TBL] [Abstract][Full Text] [Related]
6. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
[TBL] [Abstract][Full Text] [Related]
8. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
9. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation.
Nozaki I; Lunz JG; Specht S; Stolz DB; Taguchi K; Subbotin VM; Murase N; Demetris AJ
Lab Invest; 2005 Jan; 85(1):109-23. PubMed ID: 15558059
[TBL] [Abstract][Full Text] [Related]
10. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.
Oishi N; Kumar MR; Roessler S; Ji J; Forgues M; Budhu A; Zhao X; Andersen JB; Ye QH; Jia HL; Qin LX; Yamashita T; Woo HG; Kim YJ; Kaneko S; Tang ZY; Thorgeirsson SS; Wang XW
Hepatology; 2012 Nov; 56(5):1792-803. PubMed ID: 22707408
[TBL] [Abstract][Full Text] [Related]
12. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
13. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
[TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
[TBL] [Abstract][Full Text] [Related]
16. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
17. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.
Moes M; Le Béchec A; Crespo I; Laurini C; Halavatyi A; Vetter G; Del Sol A; Friederich E
PLoS One; 2012; 7(4):e35440. PubMed ID: 22514743
[TBL] [Abstract][Full Text] [Related]
18. Loss of Git2 induces epithelial-mesenchymal transition by miR146a-Cnot6L-controlled expression of Zeb1.
Zhou W; Thiery JP
J Cell Sci; 2013 Jun; 126(Pt 12):2740-6. PubMed ID: 23591815
[TBL] [Abstract][Full Text] [Related]
19. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst.
Chu CH; Chou W; Wang F; Yeh CN; Chen TC; Yeh TS
J Gastroenterol Hepatol; 2016 May; 31(5):1052-9. PubMed ID: 26479153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
